157 related articles for article (PubMed ID: 33771761)
21. Novel mutation in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism.
Lo B; Faiyaz-Ul-Haque M; Kennedy S; Aviv R; Tsui LC; Teebi AS
Am J Med Genet A; 2003 Aug; 121A(1):37-40. PubMed ID: 12900899
[TBL] [Abstract][Full Text] [Related]
22. [Bilateral giant cell central granuloma of the jaws in a Noonan syndrome: About one case with emphasizing on bone giant cell lesions of the jaws].
Sizaret D; Tallegas M; de Pinieux G
Ann Pathol; 2022 Apr; 42(3):259-263. PubMed ID: 35058088
[TBL] [Abstract][Full Text] [Related]
23. Novel nucleotide mutation leading to a recurrent amino acid alteration in SH3BP2 in a patient with cherubism.
Sangu N; Shimosato T; Inoda H; Shimada S; Shimojima K; Ando T; Yamamoto T
Congenit Anom (Kyoto); 2013 Dec; 53(4):166-9. PubMed ID: 24712477
[TBL] [Abstract][Full Text] [Related]
24. Giant Cell Lesions of the Jaws Involving RASopathy Syndromes.
Luna M; Wolsefer N; Zambrano CX; Stojanov IJ
Acta Stomatol Croat; 2022 Mar; 56(1):77-88. PubMed ID: 35382488
[TBL] [Abstract][Full Text] [Related]
25. Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages.
Prod'Homme V; Boyer L; Dubois N; Mallavialle A; Munro P; Mouska X; Coste I; Rottapel R; Tartare-Deckert S; Deckert M
J Clin Invest; 2015 Apr; 125(4):1396-400. PubMed ID: 25705883
[TBL] [Abstract][Full Text] [Related]
26. Neurofibromatosis Type 1 With Cherubism-like Phenotype, Multiple Osteolytic Bone Lesions of Lower Extremities, and Alagille-syndrome: Case Report With Literature Survey.
Friedrich RE; Zustin J; Luebke AM; Rosenbaum T; Gosau M; Hagel C; Kohlrusch FK; Wieland I; Zenker M
In Vivo; 2021; 35(3):1711-1736. PubMed ID: 33910856
[TBL] [Abstract][Full Text] [Related]
27. SH3BP2-encoding exons involved in cherubism are not associated with central giant cell granuloma.
Teixeira RC; Horz HP; Damante JH; Garlet GP; Santos CF; Nogueira RL; Cavalcante RB; Conrads G
Int J Oral Maxillofac Surg; 2011 Aug; 40(8):851-5. PubMed ID: 21680150
[TBL] [Abstract][Full Text] [Related]
28. Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation.
Kadlub N; Sessiecq Q; Mandavit M; L'Hermine AC; Badoual C; Galmiche L; Berdal A; Descroix V; Picard A; Coudert AE
Orphanet J Rare Dis; 2018 Sep; 13(1):166. PubMed ID: 30236129
[TBL] [Abstract][Full Text] [Related]
29. TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw.
Gomes CC; Gayden T; Bajic A; Harraz OF; Pratt J; Nikbakht H; Bareke E; Diniz MG; Castro WH; St-Onge P; Sinnett D; Han H; Rivera B; Mikael LG; De Jay N; Kleinman CL; Valera ET; Bassenden AV; Berghuis AM; Majewski J; Nelson MT; Gomez RS; Jabado N
Nat Commun; 2018 Nov; 9(1):4572. PubMed ID: 30385747
[TBL] [Abstract][Full Text] [Related]
30. Cherubism: a systematic literature review of clinical and molecular aspects.
Chrcanovic BR; Guimarães LM; Gomes CC; Gomez RS
Int J Oral Maxillofac Surg; 2021 Jan; 50(1):43-53. PubMed ID: 32620450
[TBL] [Abstract][Full Text] [Related]
31. A novel mutation of the SH3BP2 gene in an aggressive case of cherubism.
Carvalho VM; Perdigão PF; Pimenta FJ; de Souza PE; Gomez RS; De Marco L
Oral Oncol; 2008 Feb; 44(2):153-5. PubMed ID: 17368082
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation.
Lietman SA; Kalinchinko N; Deng X; Kohanski R; Levine MA
Hum Mutat; 2006 Jul; 27(7):717-8. PubMed ID: 16786512
[TBL] [Abstract][Full Text] [Related]
33. Cherubism - new hypotheses on pathogenesis and therapeutic consequences.
Hyckel P; Berndt A; Schleier P; Clement JH; Beensen V; Peters H; Kosmehl H
J Craniomaxillofac Surg; 2005 Feb; 33(1):61-8. PubMed ID: 15694152
[TBL] [Abstract][Full Text] [Related]
34. Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts.
Liu B; Yu SF; Li TJ
J Oral Pathol Med; 2003 Jul; 32(6):367-75. PubMed ID: 12787044
[TBL] [Abstract][Full Text] [Related]
35. Mutations of the SH3BP2 gene in 2 families of cherubism.
Tuna EB; Shimizu T; Seymen F; Yildirim M; Gencay K; Maeda T
Pediatr Dent; 2012; 34(3):198-202. PubMed ID: 22795151
[TBL] [Abstract][Full Text] [Related]
36. Idiopathic bilateral central giant cell reparative granuloma of jaws: a case report and literature review.
Orhan E; Erol S; Deren O; Sevin A; Ekici O; Erdoğan B
Int J Pediatr Otorhinolaryngol; 2010 May; 74(5):547-52. PubMed ID: 20219254
[TBL] [Abstract][Full Text] [Related]
37. Integrated proteomics, phosphoproteomics and metabolomics analyses reveal similarities among giant cell granulomas of the jaws with different genetic mutations.
Vitório JG; Duarte-Andrade FF; Pereira TDSF; Melo-Braga MN; Canuto GAB; Macedo AN; Lebron YAR; Moreira VR; Felicori LF; Lange LC; Santos LVS; Larsen MR; Gomes CC; Gomez RS
J Oral Pathol Med; 2022 Aug; 51(7):666-673. PubMed ID: 35706152
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic study of 24 cases of cherubism.
Meng XM; Yu SF; Yu GY
Int J Oral Maxillofac Surg; 2005 Jun; 34(4):350-6. PubMed ID: 16053841
[TBL] [Abstract][Full Text] [Related]
39. KRAS mutations in implant-associated peripheral giant cell granuloma.
Martins-Chaves RR; Guimarães LM; Pereira TDSF; Pereira NB; Chrcanovic BR; Fonseca FP; Lafuente-Ibáñez de Mendoza I; Aguirre-Urizar JM; Gomes CC; Gomez RS
Oral Dis; 2020 Mar; 26(2):334-340. PubMed ID: 31758745
[TBL] [Abstract][Full Text] [Related]
40. Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts.
Kittaka M; Mayahara K; Mukai T; Yoshimoto T; Yoshitaka T; Gorski JP; Ueki Y
J Bone Miner Res; 2018 Jan; 33(1):167-181. PubMed ID: 28914985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
